Overview
DOWNLOAD REGISTRATION FORM (bank transfer payment only)
ONLINE REGISTRATION (VISA credit card payment only)
***********************************************************************************
Moving towards Regulatory Harmonisation to enhance Access to Medicines in Africa
***********************************************************************************
This is the 4th African Regulatory Conference co-organised by the DIA and the IFPMA’s African Regulatory Network (ARN).
IFPMA (International Federation of Pharmaceutical Manufacturers and Associations) represents the research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry’s 1.3 million employees strive to develop and provide innovative medicines, biological products, and vaccines that improve patients’ lives worldwide. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health.
The ARN is an ad-hoc network of the Regulatory Policy and Technical Standards Committee (RPTS) of IFPMA. The association works in partnership with regulatory authorities and the pharmaceutical industry in Africa to encourage greater harmonisation of regulatory requirements with the aim to help enable faster and expanded access to good quality innovative medicines for patients.
The African Regulatory Conference offers the opportunity for key stakeholders active in the region including Representatives from health authorities, local and multinational pharmaceutical companies, international, governmental and non-governmental organisations to exchange progressive views on key topics of interest and identify focus areas for ongoing efforts aimed to increase patient access to new and improved medicines.
Simultaneous translation in French and English will be available for plenary sessions only.
To view detailed programme please click on View PDF above.
The 4th African Regulatory Conference is co-organised by
----------------------------------------------------------------------------------------------------
What participants of the 3rd African Regulatory Conference said:
"A well placed conference which has fostered the sharing of information and best practices and openly discussion delegates regarding issues facing African Regulatory authorities and industry. Great job done."
"It’s the 3rd conference to attend. I appreciate the learning received in all ARC’s."
"The meeting is a very good platform of exchange and we have learned lessons which can help us when we are back in our country."
----------------------------------------------------------------------------------------------------
Read the latest DIA Global Forum article on the 4th African Regulatory Conference
Program Committee
-
Vincent I. Ahonkhai, MD, FAAFP Senior Advisor, Global Health
Bill & Melinda Gates Foundation, United States -
Corneille Traore Director
West African Economic and Monetary Union (UEMOA) , Burkina Faso -
Nouara Ait-Aider Global Regulatory Affairs, RA ITC - Africa
Sanofi Aventis R&D, France -
Cristina Arnes Munoz Policy Analyst
IFPMA, Switzerland -
Fabienne Y. Benoist, PhD, MPH Head of Regulatory Affairs
DNDi, Switzerland -
Mercè Caturla Goñi Global Access Regulatory Leader, Regulatory Policy (Africa and WHO)
Janssen Pharmaceutical Companies of Johnson & Johnson, Belgium -
Paul Dearden Senior Director, Global Regulatory Policy
Biogen, United Kingdom -
Muriel DONA-FOLOGO, MD Head of Regulatory Affairs ICMEA
Takeda, United Arab Emirates -
Valérie Faillat-Proux, PharmD Regulatory Affairs Senior Director - Access to Medicines
Sanofi, France -
Bunmi Femi-Oyekan Director, Regulatory Affairs
Pfizer Specialities Ltd, Nigeria -
Osaretin Jaiyeola, MPharm Managing Director & Principal Partner
Fensyl MHP Consulting Limited, Nigeria -
Robert Lebeda Manager Global Regulatory Affairs - International
Eli Lilly Regional Gmbh, Austria -
Caroline Mendy Manager, Regulatory Policy
IFPMA, Switzerland -
John Mwangi Head of Regulatory Affairs - Middle Africa
Bayer East Africa Ltd, Kenya -
Sharmila Parsotam Senior Director
Pfizer, United Kingdom -
Dakshina Reddy VP Regulatory
Altimmune, United States -
Christophe Saillez Senior Manager
GSK Biologicals, Belgium -
Myriam Sedrati Regulatory Affairs Director North and West Africa
Merck Sharp & Dohme, Morocco -
Nathalie Tatarczuk Regulatory Affair Pharmacist
Merck Sharp & Dohme, Morocco
Have an account?
Ways to register
Registration fee includes conference delegate material, refreshments and lunches.
Registration fee can be settled via bank transfer or by Visa and MasterCard credit cards.